According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
Mount Elizabeth Royal Square: Specialised Day Care, All in a Day
Parkway Radiology Launches MammoXpress to Bring Preventive Care Closer to Women
Mount Elizabeth Hospital Walks the Talk for Health and Community
Championing Mental Health: Care That Empowers, Where It Matters
"Care That Empowers, Where It Matters" is at the heart of IHH Healthcare's Mental Health Week from 11 to 17 October 2025 to foster a supportive workplace.
Premier Integrated Labs Transforms Operations with Cutting-edge Haematology System
On 16 October, Premier Integrated Labs redefined laboratory excellence with Malaysia’s first AI-assisted, fully automated haematology system in private practice, shaping the future of diagnostic innovation.
Transforming Our Future: A Decade of Quality & Safety
The 10th IHH Healthcare Quality Summit 2025 in Hong Kong brought together more than 200 leaders, clinicians and quality champions from across our global network to reaffirm our commitment to clinical excellence, patient safety, and transformative care.
